Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease

StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv26
  2. Site contact updatedv25
  3. 4 versions Re-verified since Apr 20, 2020, no change to tracked fieldsv21-v24
  4. Study completion date: Jan 2099
    • Site contact updated
    v20
  5. Primary completion date: Jun 2016 to Jan 2099
    • Study completion date: Jun 2017 to not stated
    • Start date: Jun 1999 to Jan 1999
    v19
Show 17 earlier versionsHide 17 earlier versions
  1. Eligibility criteria expanded, about 45 wordsv18
  2. Site contact updatedv17
  3. Site contact updatedv16
  4. Study Status, Outcome Measuresv15
  5. 2 versions Re-verified since Jul 5, 2012, no change to tracked fieldsv13-v14
  6. Study completion date: Jun 2017
    • Collaborators: 3 to 2
    v12
  7. Re-verified, no change to tracked fieldsv11
  8. Site contact updatedv10
  9. Primary completion date: Jun 2016
    • Eligibility criteria revised
    v9
  10. Eligibility criteria revised
    • Site contact updated
    v8
  11. Re-verified, no change to tracked fieldsv7
  12. Site contact updated
    • Collaborators: 4 to 3
    v6
  13. Enrollment target: 9999
    • Eligibility criteria revised
    • Study site revised
    • Collaborators expanded, about 13 words
    v5
  14. Re-verified, no change to tracked fieldsv4
  15. Eligibility criteria expanded, about 8 wordsv3
  16. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.
Trial Details
NCT Number NCT00398177
Lead Sponsor Stanford University
Collaborators: The Leukemia and Lymphoma Society, Biospect Inc
Conditions
(from sponsor)		 Lymphoma, Non-Hodgkin, Hodgkin's Disease
Related terms Hodgkin Disease, Lymphoma, Non-Hodgkin
Enrollment 9,999 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov